Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.

Abstract

The natural history of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is dismal (approximately 2-4 mo), and PVTT is reportedly found in 10%-40% of HCC patients at diagnosis. According to the Barcelona Clinic Liver Cancer (BCLC) Staging System (which is the most widely adopted HCC management guideline), sorafenib is the standard of… (More)
DOI: 10.3748/wjg.v22.i1.407

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.